Sie befinden sind hier: Startseite > Börse > Unternehmensnachrichten > Keymed Biosciences New York China California

Keymed, Biosciences

Keymed Biosciences New York China California

07.08.2025 - 18:06:02

Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Gastrointestinal Cancers

View original content:https://www.prnewswire.co.uk/news-releases/keymed-biosciences-announces-approval-of-ind-for-cm518d1-by-the-national-medical-products-administration-of-china-for-the-treatment-of-gastrointestinal-cancers-302438097.html

@ prnewswire.co.uk